On Jan 25, 2022 Cellino Biotech closed a Series A round and raised $80,000,000 from Leaps by Bayer, featuring lead investors Leaps by Bayer.
About the company: Cellino Biotech is located at United States, North America.
“Every human every cell, regenerative medicine, cell therapies.”
Company website: http://www.cellinobio.com